Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Antidepressants (ADs) are widely used among elderly persons, making AD-related safety an important issue. AREAS COVERED: This review highlights safety considerations related to AD use including risks associated with inappropriate and off-label use. The age-related pharmacokinetic and pharmacodynamic changes underlying safety concerns connected to ADs are outlined. Drug-drug interactions as a cause of AD-related adverse drug reactions (ADRs) are also discussed. We reviewed scientific evidence concerning three important safety outcomes related to ADs in elderly persons: cardiac arrhythmias, hyponatraemia and falls/fractures. EXPERT OPINION: Several AD-related ADRs in elderly people are likely to be preventable. Current evidence suggests that selective serotonin re-uptake inhibitors (SSRIs) are best avoided particularly in persons with kidney disease due to the risk of hyponatraemia. The use of tricyclic antidepressants (TCAs) should be limited in the elderly due to anticholinergic adverse effects. TCAs should also be avoided in elderly persons at high risk of cardiovascular events due to a risk of cardiac arrhythmia. Emerging evidence suggests that SSRIs also have arrhythmogenic potential. Both TCAs and SSRIs should be used cautiously in elderly persons at risk of falls. Future research in this area should aim to investigate the lowest effective dose of AD possible, the relationship between AD dose and adverse effects, and which elderly subgroups are most prone to develop severe ADRs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821
Antidepressant use and risk of adverse outcomes in older people: population based cohort study
Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J. (2011) · BMJ · doi:10.1136/bmj.d4551 · Cited by 833 · cited 1×
“Some observational studies have highlighted the association between ADs and hip fractures [66-68].”
BackgroundMeeks, T. W., Vahia, I. V., Lavretsky, H., Kulkarni, G., & Jeste, D. V. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.09.015 · Cited by 569
Changes in the structural complexity of the aged brain
Dickstein, D. L., Kabaso, D., Rocher, A. B., Luebke, J. I., Wearne, S. L., & Hof, P. R. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00289.x · Cited by 460 · cited 1×
“Older patients may require a lower AD drug dosage due to an increase in pharmacodynamic sensitivity, for example, due to structural and physiological changes in neurons and neurotransmission [13,14].”
BackgroundKatona, C., Hansen, T., & Olsen, C. K. (2012) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283542457 · Cited by 445 · cited 1×
“Other drugs, such as vortioxetine, levomilnacipran, vilazodone, desvenlafaxine and desvenlafaxine, were already approved for major depression in adults but much more information on the safety of these newer ADs in elderly patients is needed, although there are emerging data for vortioxetine in elderly patients [77].”
BackgroundBakken, M. S., Engeland, A., Engesæter, L. B., Ranhoff, A. H., Hunskaar, S., & Ruths, S. (2013) · Age and Ageing · doi:10.1093/ageing/aft009 · Cited by 85
Cited by
Moisset, X., Bouhassira, D., Avez Couturier, J., Alchaar, H., Conradi, S., Delmotte, M. H., Lanteri-Minet, M., Lefaucheur, J. P., Mick, G., Piano, V., et al. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.01.361 · Cited by 450
Orgeta, V., Tabet, N., Nilforooshan, R., & Howard, R. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161247 · Cited by 203
Rothschild, A. J., Parikh, S. V., Hain, D., Law, R., Thase, M. E., Dunlop, B. W., DeBattista, C., Conway, C. R., Forester, B. P., Shelton, R. C., et al. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2020.113649 · Cited by 20
Hippocampal MicroRNAs Respond to Administration of Antidepressant Fluoxetine in Adult Mice
Miao, N., Jin, J., Kim, S.-N., & Sun, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030671 · Cited by 19
Metadata
- Authors
- Sultana, J., Spina, E., & Trifirò, G.
- Venue
- Expert Opinion on Drug Metabolism & Toxicology
- Publisher
- Informa UK Limited
- Published
- 2015-03-03
- Volume
- 11
- Issue
- 6
- Pages
- 883-892
- ISSN
- 1742-5255 (ISSN-L)
- 1744-7607
- OpenAlex
- W2095482141
- Cited by
- 87
- References
- 6
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety. https://app.cochat.ai/papers/10.1517/17425255.2015.1021684
- The paper
- Sultana, J., Spina, E., & Trifirò, G. (2015). Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1517/17425255.2015.1021684
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.